Atypical naevi, Clark's naevi or ‘funny-looking’ moles, are common and are important simulants of melanoma. Melanoma may appear identical clinically and on dermoscopy, requiring biopsy to distinguish them. Stable naevi are much more common than malignant lesions, and so only those at highest risk should be excised. Pathologists may also have difficulty making the diagnosis.
Some authors distinguish ‘dysplastic naevi’ from other atypical naevi (others use the terms synonymously). Dysplastic naevi have at least 3 of the following clinical characteristics:
A patient may have a single distinctive dysplastic naevus, or multiple dysplastic naevi. A high grade solitary dysplastic naevus may be difficult to distinguish from melanoma, and is best excised. Multiple dysplastic naevi should be monitored. They may indicate a patient's predisposition to melanoma, particularly if there is a family history of melanoma (atypical mole or dysplastic naevus syndrome). The melanoma may arise from a precursor dysplastic naevus but more often arises de novo.
In this course, the term atypical naevi will encompass a broad range of naevi with unusual clinical and dermoscopic features that are benign on histology.
The dermoscopic features discriminating between atypical naevi and melanoma require expert interpretation and may be misleading. Atypical naevi may have an irregular pattern of pigment distribution but do not reveal specific features of melanoma. However, it can be extremely difficult or impossible to distinguish melanoma from atypical naevus.
The best clues for histological atypia appear to be related to structural features and pigment distribution. Frequently a patient with multiple atypical naevi has a predominance of one type.
Possible structures in atypical naevi include:
The presence of all three types of structure is very suggestive of melanoma. It has also been shown that naevi showing complex dermoscopic pattern are more prevalent in patients who develop melanoma, i.e., naevi in which there are network, globules +/- structureless areas.
The distribution of pigmentation may be:
Naevi with central amorphous hyperpigmentation are often seen in midlife and may have a scaly surface. Removing the scale by tape stripping may reveal a reticular pattern.
Combined macular and papular components are common features of atypical naevi. The term compound naevus is used if there are junctional and dermal components. The term combined naevus is used when the dermal component is a deeply pigmented blue naevus.
The next few images show naevi that appeared clinically atypical but had benign histology.
Other dermoscopic features of atypical naevi may include:
Spitz naevi present as evolving lesions and tend to be pink (classic) or black (pigmented or Reed type). They often arise in children and eventually involute. They may be clinically, dermoscopically and histologically difficult to distinguish from melanoma.
Several dermoscopic patterns have been described for Spitz naevi.
A proportion of benign naevi may be observed to change by dermoscopic monitoring at intervals of months to years. This is particularly likely in childhood, when naevi often change from globular pattern to network pattern and sometimes to a homogeneous structure. Sun exposure may cause globules and dots to disappear or move from the centre to the periphery.
Some changes seen in benign moles are unrelated to malignancy:
Changing shape, size or structure of flat atypical naevi are more worrying. About 10 to 15% of these will prove to be melanoma. If changes are mild, it may be reasonable to review the dermoscopy in 3 months.
There should be a low threshold for excision in changing atypical naevi that are elevated, because of rapid growth and relatively poor prognosis of nodular melanoma.
Describe the evidence that serial photography with dermoscopy enables early diagnosis of melanoma in patients with atypical naevi.
See the DermNet NZ bookstore.
© 2019 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.